Related Experiment Video
Updated: Aug 2, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Advancing the field of drug delivery: taking aim at cancer
Marsha A Moses1, Henry Brem, Robert Langer
1The Vascular Biology Program, Children's Hospital and the Department of Surgery, Children's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Drug delivery systems for cancer therapeutics have now been used by millions of patients and have resulted in the creation of new therapies as well as significantly improving existing ones. Here we discuss a number of the drug delivery systems that have been approved by regulatory authorities and that are currently in clinical use, such as controlled delivery of cancer therapeutics, local chemotherapy, polymer drug conjugates, liposomal systems, and transdermal drug delivery patches. The next generation of "smart" drug delivery approaches such as controlled release microchips are discussed as are some of the future challenges and directions in this field.
Insights
Advanced drug delivery systems improve cancer treatment efficacy. This review covers approved therapies like liposomal systems and transdermal patches, and future innovations such as smart microchips for better cancer drug delivery.
Area of Science:
- Oncology and Pharmaceutical Sciences
- Biomedical Engineering
Background:
- Drug delivery systems (DDS) are integral to modern cancer therapeutics.
- Millions of patients have benefited from existing DDS, leading to new treatment options and improved outcomes.
Purpose of the Study:
- To review regulatory-approved and clinically utilized cancer drug delivery systems.
- To discuss emerging "smart" drug delivery technologies and future challenges in the field.
Main Methods:
- Review of regulatory-approved drug delivery systems for cancer therapeutics.
- Discussion of current clinical applications including controlled delivery, local chemotherapy, polymer conjugates, liposomal systems, and transdermal patches.
- Exploration of next-generation technologies like controlled release microchips.
Main Results:
- Several drug delivery systems are approved and in clinical use, enhancing cancer therapy.
- Established systems include controlled delivery, local chemotherapy, polymer drug conjugates, liposomal systems, and transdermal patches.
- Future directions involve "smart" systems like controlled release microchips.
Conclusions:
- Drug delivery systems have significantly advanced cancer treatment.
- Current systems offer diverse therapeutic strategies, with ongoing innovation promising further improvements.
- Future research should address challenges in developing and implementing next-generation smart drug delivery systems for oncology.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

